Navigation Links
MedWaves, Incorporated Announces Receipt of Taiwan Food and Drug Administration (TFDA) Certification to Import and Sell Its Patented AveCure™ Microwave Ablation System and Devices
Date:9/21/2011

SAN DIEGO, Sept. 21, 2011 /PRNewswire/ -- MedWaves' AveCure™ microwave coagulation-ablation (MWA) system uses microwave energy to volumetrically coagulate-ablate (destroy) soft-tissue lesions (abnormal structures) safely, effectively, precisely and with repeatability. The system has successfully treated over 1,000 patients worldwide, including lesions in bone, kidney, liver, lung and pancreas. The Company plans to bring its technology to treat lesions in other locations in the body. The Company's technology makes available treatment options for many cancer patients in either early or late stage and helps those who are running out of options.

Taiwan, with over 23 million in population, is one of 15 highly developed Asian countries in the region, an important market for MedWaves. As with other developed countries in the region, its cancer incidence rate is on the rise, and cancer remains the leading cause of death in Taiwan as its life expectancy continues to rise according to Taiwan Today, June 2011. The five most common types of cancer in 2008 were colon, liver, lung, breast and oral cancer according to Taiwan Central News Agency, April 2011. MedWaves is pleased to announce the receipt of TFDA certification to import and sell its products to help those in need. MedWaves will work in close coordination with its Taiwanese distributor-partners to schedule and conduct clinical evaluations for the sale of its AveCure™ system in key hospitals in Taiwan. Earlier this year, Hong Kong University published its successful treatment of tumors in the liver using the MedWaves AveCure™ microwave ablation system. The Hong Kong University has adopted the MedWaves™ AveCure system as a cancer treatment tool.

About AveCure™ Microwave Coagulation-Ablation System and Devices:

MedWaves AveCure™ Microwave Coagulation-Ablation System overcomes the limitations of other microwave and radiofrequency (RF) thermal ablation technologies to destroy lesions safely, effectively, precisely and with repeatability and uniformity. It is the only system approved in the market to provide clinicians with patented, fully integrated real-time temperature, both forward and reverse-power feedback to control energy delivery intelligently. The system, which consists of a generator, extension cable set, and an array of single-patient-use microwave-probe devices, enables the surgeons and interventional radiologists to treat soft-tissue lesions, such as tumors, safely and easily, with confidence. This single-patient-use device provides MedWaves with a continuous growth of revenue stream.

MedWaves AveCure™ Microwave Coagulation-Ablation System has also received USFDA approval for sales in the United States*, CE Mark for sales in the European Union, KFDA certification for import and sales in Korea, and SFDA certification for import and sales in China. Other received approval and certification announcements to follow.

About MedWaves, Incorporated

MedWaves, Inc., a United States company based in San Diego, California, develops innovative and proprietary microwave ablation technology for the minimally invasive coagulation-ablation products for soft tissue lesions, such as tumors. The Company's management team has extensive experience in the medical device marketplace. The Company's proprietary technology allows for the development of minimally invasive microwave antenna devices in a wide range of sizes, shapes and flexibility to meet the clinicians' requirements in the treatment of lesions in bone, kidney, liver, lung, pancreas and other locations in the body. MedWaves maintains California FDB and ISO 13485 Certifications to manufacture and distribute microwave coagulation-ablation system.

Contact Information:

Theodore Ormsby (email: tedormsby@avecure.com)  
Mobile: (858) 342-3331

George Leung, PhD (email: gleung@avecure.com)  
Mobile: (858) 705-5056

16760 W Bernardo Drive, San Diego, CA 92127        
Tel: (858) 946-0015              
Website: http://www.medwaves.com  

*The system is not intended for use in cardiac procedures.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE MedWaves, Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Accuray Incorporated to Speak at UBS Global Life Sciences Conference
2. Spherix Incorporated to Present at the Rodman & Renshaw 13th Annual Healthcare Conference
3. Accuray Incorporated to Host Investor Meeting at ASTRO 2011
4. Proacta Incorporated and Yakult Honsha Announce Expansion of Their Collaborative Research, Development and Commercialization Agreement
5. ULURU Inc. Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor
6. Accuray Incorporateds CEO to Speak at Jefferies 2011 Global Healthcare Conference
7. Accuray Incorporated Announces HSR Clearance in Acquisition of TomoTherapy
8. Accuray Incorporated to Report Financial Results for Third Quarter of Fiscal 2011
9. Accuray Incorporated to Speak at 10th Annual Needham Healthcare Conference
10. Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering
11. Proacta Incorporated and Yakult Honsha Announce an Agreement for the Collaborative Research, Development and Commercialization for Proactas PR509 Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... Phoenix Marketing Solutions ( Phoenix ) ... mission of transforming science into clinical practice. During a time ... innovative approach supports the life sciences industry by ... in science and medicine — which ultimately improves lives. ... 2002 by Tracy Doyle and Angela Fiordilino ...
(Date:4/25/2017)... 25, 2017 Endo International plc (NASDAQ: ENDP ... Members of its senior management team will host a conference call ... ET. The dial-in number to access the call ... and the passcode is 6086379. Please dial in 10 minutes prior ... A replay of the call will be available from May 9, ...
(Date:4/24/2017)... 2017 SW Safety Solutions, Inc., the industry,s ... the release of the latest advancement in workplace single-use ... of leading edge nitrile glove technology features SW,s patent ... tactile grip on wet and oily surfaces and the ... and a suite of other advanced SW technologies, the ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Bill Howe started his sewer and drain ... After Tina Howe joined the team, the Bill Howe brand was born and they ... rates, and giving back to the San Diego community in which they worked, lived ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... responds to and which He does not. Yisrayl says with so many titles and ... true name, but he says with a little Scripture, backed with a lot of research, ...
(Date:4/28/2017)... ... 2017 , ... Researchers at Moffitt Cancer Center ... Data Hub in a sample of participants enrolled in an ongoing cancer quality-of-life ... solutions for the global scientific community. The company’s new CentrePoint Data Hub is ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA is pleased ... has 20+ years of experience within the beauty industry, ranging from marketing, retail ... of high-end cosmetic brands, retail brands and outlets in Canada and New York. ...
(Date:4/28/2017)... ... , ... Intellitec Solutions announced the publication of a case ... GP solution that integrates to their PointClickCare EHR software package. With the guidance ... Grove now has the capability to achieve its goal for a comprehensive EHR ...
Breaking Medicine News(10 mins):